Stay updated on Nivolumab and Talimogene in Pleural Effusion Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page.

Latest updates to the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page
- Check2 days agoChange DetectedThe study record for the nivolumab and intrapleural talimogene laherparepvec trial is now displayed, including its terminated status, eligibility criteria, treatment plan, outcomes, and posted results information.SummaryDifference52%

- Check9 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedAn NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” across NIH content. The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check23 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1. The page continues to show a 403 error instead of the study record.SummaryDifference0.2%

- Check50 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study record content, replacing the visible details with an error screen while the site chrome remains.SummaryDifference19%

Stay in the know with updates to Nivolumab and Talimogene in Pleural Effusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page.